REGENXBIO Inc.RGNXNASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank67
5Y CAGR-21.0%
Studio
Year-over-Year Change

Year-over-year revenue growth rate

5Y CAGR
-21.0%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
3 yr
Consecutive growthRecovering
PeriodValue
2025104.54%
2024-7.66%
2023-19.94%
2022-76.03%
2021204.30%
2020338.70%
2019-83.88%
20182002.42%
2017126.48%
2016-39.52%